Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinical and Experimental Dermatology
|
June 11, 2009
Spontaneous regression of primary cutaneous Epstein-Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient
L S Chiu, P C L Choi, N M Luk, et al.
Alimentary Pharmacology & Therapeutics
|
February 26, 2010
Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B
G L H Wong, V W S Wong, P C L Choi, et al.
Alimentary Pharmacology & Therapeutics
|
November 23, 2013
Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B
G L-H Wong, H L-Y Chan, P C-L Choi, et al.
Alimentary Pharmacology & Therapeutics
|
March 12, 2014
Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations
G L-H Wong, H L-Y Chan, Z Yu, et al.
Journal of Viral Hepatitis
|
August 5, 2008
Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B
H L-Y Chan, G L-H Wong, P C-L Choi, et al.
Alimentary Pharmacology & Therapeutics
|
May 3, 2017
Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease
J Pang, W Xu, X Zhang, et al.
Gut
|
October 4, 2008
Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B
G L-H Wong, V W-S Wong, P C-L Choi, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2012
Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers
J Shen, H L-Y Chan, G L-H Wong, et al.
Alimentary Pharmacology & Therapeutics
|
November 28, 2008
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels
V W-S Wong, G L-H Wong, S W-C Tsang, et al.
Alimentary Pharmacology & Therapeutics
|
January 15, 2014
PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome
J Shen, G L-H Wong, H L-Y Chan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinical and Experimental Dermatology
|
June 11, 2009
Spontaneous regression of primary cutaneous Epstein-Barr virus-positive, CD30-positive anaplastic large T-cell lymphoma in a heart-transplant recipient
L S Chiu, P C L Choi, N M Luk, et al.
Alimentary Pharmacology & Therapeutics
|
February 26, 2010
Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B
G L H Wong, V W S Wong, P C L Choi, et al.
Alimentary Pharmacology & Therapeutics
|
November 23, 2013
Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B
G L-H Wong, H L-Y Chan, P C-L Choi, et al.
Alimentary Pharmacology & Therapeutics
|
March 12, 2014
Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations
G L-H Wong, H L-Y Chan, Z Yu, et al.
Journal of Viral Hepatitis
|
August 5, 2008
Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B
H L-Y Chan, G L-H Wong, P C-L Choi, et al.
Alimentary Pharmacology & Therapeutics
|
May 3, 2017
Significant positive association of endotoxemia with histological severity in 237 patients with non-alcoholic fatty liver disease
J Pang, W Xu, X Zhang, et al.
Gut
|
October 4, 2008
Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B
G L-H Wong, V W-S Wong, P C-L Choi, et al.
Alimentary Pharmacology & Therapeutics
|
October 17, 2012
Assessment of non-alcoholic fatty liver disease using serum total cell death and apoptosis markers
J Shen, H L-Y Chan, G L-H Wong, et al.
Alimentary Pharmacology & Therapeutics
|
November 28, 2008
Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels
V W-S Wong, G L-H Wong, S W-C Tsang, et al.
Alimentary Pharmacology & Therapeutics
|
January 15, 2014
PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome
J Shen, G L-H Wong, H L-Y Chan, et al.
Page
of 1